High-intensity focused ultrasound (HIFU) for adenomyosis: Two-year follow-up results
•Evaluation of the long-term improvement of clinical symptoms with high intensity focused ultrasound (HIFU).•Ultrasound-guided high intensity focused ultrasound (USgHIFU) modality was used.•Among the 350 treated patients, 224 completed the two years follow-up.•USgHIFU treatment can sustain long-term...
Gespeichert in:
| Veröffentlicht in: | Ultrasonics sonochemistry 2015-11, Vol.27, p.677-681 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 681 |
|---|---|
| container_issue | |
| container_start_page | 677 |
| container_title | Ultrasonics sonochemistry |
| container_volume | 27 |
| creator | Shui, Lian Mao, Shihua Wu, Qingrong Huang, Guohua Wang, Jian Zhang, Ruitao Li, Kequan He, Jia Zhang, Lian |
| description | •Evaluation of the long-term improvement of clinical symptoms with high intensity focused ultrasound (HIFU).•Ultrasound-guided high intensity focused ultrasound (USgHIFU) modality was used.•Among the 350 treated patients, 224 completed the two years follow-up.•USgHIFU treatment can sustain long-term clinical improvements.•USgHIFU is a safe and effective treatment for adenomyosis.
To evaluate the long-term improvement of clinical symptoms of adenomyosis after treatment with ultrasound-guided high intensity focused ultrasound (USgHIFU).
From January 2010 to December 2011, 350 patients with adenomyosis were treated with USgHIFU. Among the 350 patients, 224 of them completed the two years follow-up. The patients were followed up at 3months, 1year, and 2years after HIFU treatment. Adverse effects and complications were recorded.
All patients completed HIFU ablation without severe postoperative complications. 203 of the 224 patients who showed varying degrees of dysmenorrhea before treatment had the symptom scores decreased significantly after treatment (P |
| doi_str_mv | 10.1016/j.ultsonch.2015.05.024 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1697220330</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1350417715001534</els_id><sourcerecordid>1697220330</sourcerecordid><originalsourceid>FETCH-LOGICAL-c438t-8079238f82b440a7a0df38168ae208abde5dc0d0845dd071667c919344bef13</originalsourceid><addsrcrecordid>eNqFUMtOwzAQtBAIyuMXUI7lkLJ-JHE4gRClSEgcKGfLtTfgKo2LnYD697hq4Yq00q40Mzu7Q8glhQkFWl4vJ0PbR9-ZjwkDWkwgFRMHZERlxXMmmTxMMy8gF7SqTshpjEsA4DWDY3LCSiigBDEi85l7_8hd12MXXb_JGm-GiDZL24OOfuhsNp49Td-uEhIybbHzq42PLt5k82-fb1CHhLSt_86HdRYwbs86J0eNbiNe7PsZeZ0-zO9n-fPL49P93XNuBJd9LqGqGZeNZAshQFcabMMlLaVGBlIvLBbWgAUpCmuhomVZmZrWXIgFNpSfkfFu6zr4zwFjr1YuGmxb3aEfoqJlXTEGnEOiljuqCT7GgI1aB7fSYaMoqG2eaql-81TbPBWkYiIJL_cew2KF9k_2G2Ai3O4ImP78chhUNA47g9YFNL2y3v3n8QPzhIpB</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1697220330</pqid></control><display><type>article</type><title>High-intensity focused ultrasound (HIFU) for adenomyosis: Two-year follow-up results</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Shui, Lian ; Mao, Shihua ; Wu, Qingrong ; Huang, Guohua ; Wang, Jian ; Zhang, Ruitao ; Li, Kequan ; He, Jia ; Zhang, Lian</creator><creatorcontrib>Shui, Lian ; Mao, Shihua ; Wu, Qingrong ; Huang, Guohua ; Wang, Jian ; Zhang, Ruitao ; Li, Kequan ; He, Jia ; Zhang, Lian</creatorcontrib><description>•Evaluation of the long-term improvement of clinical symptoms with high intensity focused ultrasound (HIFU).•Ultrasound-guided high intensity focused ultrasound (USgHIFU) modality was used.•Among the 350 treated patients, 224 completed the two years follow-up.•USgHIFU treatment can sustain long-term clinical improvements.•USgHIFU is a safe and effective treatment for adenomyosis.
To evaluate the long-term improvement of clinical symptoms of adenomyosis after treatment with ultrasound-guided high intensity focused ultrasound (USgHIFU).
From January 2010 to December 2011, 350 patients with adenomyosis were treated with USgHIFU. Among the 350 patients, 224 of them completed the two years follow-up. The patients were followed up at 3months, 1year, and 2years after HIFU treatment. Adverse effects and complications were recorded.
All patients completed HIFU ablation without severe postoperative complications. 203 of the 224 patients who showed varying degrees of dysmenorrhea before treatment had the symptom scores decreased significantly after treatment (P<0.001). The relief rate was 84.7%, 84.7%, and 82.3%, respectively at 3months, 1year, and 2years after treatment. The menstrual volume in 109 patients with menorrhagia was significantly improved after treatment (P<0.001) with a relief rate of 79.8%, 80.7%, and 78.9%, respectively at 3months, 1year, and 2years after HIFU treatment.
With its ability to sustain long-term clinical improvements, HIFU is a safe and effective treatment for adenomyosis.</description><identifier>ISSN: 1350-4177</identifier><identifier>EISSN: 1873-2828</identifier><identifier>DOI: 10.1016/j.ultsonch.2015.05.024</identifier><identifier>PMID: 26050604</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adenomyosis ; Adenomyosis - complications ; Adenomyosis - physiopathology ; Adenomyosis - surgery ; Adult ; Adverse effect ; Dysmenorrhea - complications ; Female ; Follow-Up Studies ; High-Intensity Focused Ultrasound Ablation - adverse effects ; Humans ; Long-term follow-up ; Menstruation ; Middle Aged ; Treatment Outcome ; Ultrasound-guided high-intensity focused ultrasound ; Young Adult</subject><ispartof>Ultrasonics sonochemistry, 2015-11, Vol.27, p.677-681</ispartof><rights>2015 Elsevier B.V.</rights><rights>Copyright © 2015 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c438t-8079238f82b440a7a0df38168ae208abde5dc0d0845dd071667c919344bef13</citedby><cites>FETCH-LOGICAL-c438t-8079238f82b440a7a0df38168ae208abde5dc0d0845dd071667c919344bef13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ultsonch.2015.05.024$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26050604$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shui, Lian</creatorcontrib><creatorcontrib>Mao, Shihua</creatorcontrib><creatorcontrib>Wu, Qingrong</creatorcontrib><creatorcontrib>Huang, Guohua</creatorcontrib><creatorcontrib>Wang, Jian</creatorcontrib><creatorcontrib>Zhang, Ruitao</creatorcontrib><creatorcontrib>Li, Kequan</creatorcontrib><creatorcontrib>He, Jia</creatorcontrib><creatorcontrib>Zhang, Lian</creatorcontrib><title>High-intensity focused ultrasound (HIFU) for adenomyosis: Two-year follow-up results</title><title>Ultrasonics sonochemistry</title><addtitle>Ultrason Sonochem</addtitle><description>•Evaluation of the long-term improvement of clinical symptoms with high intensity focused ultrasound (HIFU).•Ultrasound-guided high intensity focused ultrasound (USgHIFU) modality was used.•Among the 350 treated patients, 224 completed the two years follow-up.•USgHIFU treatment can sustain long-term clinical improvements.•USgHIFU is a safe and effective treatment for adenomyosis.
To evaluate the long-term improvement of clinical symptoms of adenomyosis after treatment with ultrasound-guided high intensity focused ultrasound (USgHIFU).
From January 2010 to December 2011, 350 patients with adenomyosis were treated with USgHIFU. Among the 350 patients, 224 of them completed the two years follow-up. The patients were followed up at 3months, 1year, and 2years after HIFU treatment. Adverse effects and complications were recorded.
All patients completed HIFU ablation without severe postoperative complications. 203 of the 224 patients who showed varying degrees of dysmenorrhea before treatment had the symptom scores decreased significantly after treatment (P<0.001). The relief rate was 84.7%, 84.7%, and 82.3%, respectively at 3months, 1year, and 2years after treatment. The menstrual volume in 109 patients with menorrhagia was significantly improved after treatment (P<0.001) with a relief rate of 79.8%, 80.7%, and 78.9%, respectively at 3months, 1year, and 2years after HIFU treatment.
With its ability to sustain long-term clinical improvements, HIFU is a safe and effective treatment for adenomyosis.</description><subject>Adenomyosis</subject><subject>Adenomyosis - complications</subject><subject>Adenomyosis - physiopathology</subject><subject>Adenomyosis - surgery</subject><subject>Adult</subject><subject>Adverse effect</subject><subject>Dysmenorrhea - complications</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>High-Intensity Focused Ultrasound Ablation - adverse effects</subject><subject>Humans</subject><subject>Long-term follow-up</subject><subject>Menstruation</subject><subject>Middle Aged</subject><subject>Treatment Outcome</subject><subject>Ultrasound-guided high-intensity focused ultrasound</subject><subject>Young Adult</subject><issn>1350-4177</issn><issn>1873-2828</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUMtOwzAQtBAIyuMXUI7lkLJ-JHE4gRClSEgcKGfLtTfgKo2LnYD697hq4Yq00q40Mzu7Q8glhQkFWl4vJ0PbR9-ZjwkDWkwgFRMHZERlxXMmmTxMMy8gF7SqTshpjEsA4DWDY3LCSiigBDEi85l7_8hd12MXXb_JGm-GiDZL24OOfuhsNp49Td-uEhIybbHzq42PLt5k82-fb1CHhLSt_86HdRYwbs86J0eNbiNe7PsZeZ0-zO9n-fPL49P93XNuBJd9LqGqGZeNZAshQFcabMMlLaVGBlIvLBbWgAUpCmuhomVZmZrWXIgFNpSfkfFu6zr4zwFjr1YuGmxb3aEfoqJlXTEGnEOiljuqCT7GgI1aB7fSYaMoqG2eaql-81TbPBWkYiIJL_cew2KF9k_2G2Ai3O4ImP78chhUNA47g9YFNL2y3v3n8QPzhIpB</recordid><startdate>20151101</startdate><enddate>20151101</enddate><creator>Shui, Lian</creator><creator>Mao, Shihua</creator><creator>Wu, Qingrong</creator><creator>Huang, Guohua</creator><creator>Wang, Jian</creator><creator>Zhang, Ruitao</creator><creator>Li, Kequan</creator><creator>He, Jia</creator><creator>Zhang, Lian</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20151101</creationdate><title>High-intensity focused ultrasound (HIFU) for adenomyosis: Two-year follow-up results</title><author>Shui, Lian ; Mao, Shihua ; Wu, Qingrong ; Huang, Guohua ; Wang, Jian ; Zhang, Ruitao ; Li, Kequan ; He, Jia ; Zhang, Lian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c438t-8079238f82b440a7a0df38168ae208abde5dc0d0845dd071667c919344bef13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adenomyosis</topic><topic>Adenomyosis - complications</topic><topic>Adenomyosis - physiopathology</topic><topic>Adenomyosis - surgery</topic><topic>Adult</topic><topic>Adverse effect</topic><topic>Dysmenorrhea - complications</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>High-Intensity Focused Ultrasound Ablation - adverse effects</topic><topic>Humans</topic><topic>Long-term follow-up</topic><topic>Menstruation</topic><topic>Middle Aged</topic><topic>Treatment Outcome</topic><topic>Ultrasound-guided high-intensity focused ultrasound</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shui, Lian</creatorcontrib><creatorcontrib>Mao, Shihua</creatorcontrib><creatorcontrib>Wu, Qingrong</creatorcontrib><creatorcontrib>Huang, Guohua</creatorcontrib><creatorcontrib>Wang, Jian</creatorcontrib><creatorcontrib>Zhang, Ruitao</creatorcontrib><creatorcontrib>Li, Kequan</creatorcontrib><creatorcontrib>He, Jia</creatorcontrib><creatorcontrib>Zhang, Lian</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Ultrasonics sonochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shui, Lian</au><au>Mao, Shihua</au><au>Wu, Qingrong</au><au>Huang, Guohua</au><au>Wang, Jian</au><au>Zhang, Ruitao</au><au>Li, Kequan</au><au>He, Jia</au><au>Zhang, Lian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High-intensity focused ultrasound (HIFU) for adenomyosis: Two-year follow-up results</atitle><jtitle>Ultrasonics sonochemistry</jtitle><addtitle>Ultrason Sonochem</addtitle><date>2015-11-01</date><risdate>2015</risdate><volume>27</volume><spage>677</spage><epage>681</epage><pages>677-681</pages><issn>1350-4177</issn><eissn>1873-2828</eissn><abstract>•Evaluation of the long-term improvement of clinical symptoms with high intensity focused ultrasound (HIFU).•Ultrasound-guided high intensity focused ultrasound (USgHIFU) modality was used.•Among the 350 treated patients, 224 completed the two years follow-up.•USgHIFU treatment can sustain long-term clinical improvements.•USgHIFU is a safe and effective treatment for adenomyosis.
To evaluate the long-term improvement of clinical symptoms of adenomyosis after treatment with ultrasound-guided high intensity focused ultrasound (USgHIFU).
From January 2010 to December 2011, 350 patients with adenomyosis were treated with USgHIFU. Among the 350 patients, 224 of them completed the two years follow-up. The patients were followed up at 3months, 1year, and 2years after HIFU treatment. Adverse effects and complications were recorded.
All patients completed HIFU ablation without severe postoperative complications. 203 of the 224 patients who showed varying degrees of dysmenorrhea before treatment had the symptom scores decreased significantly after treatment (P<0.001). The relief rate was 84.7%, 84.7%, and 82.3%, respectively at 3months, 1year, and 2years after treatment. The menstrual volume in 109 patients with menorrhagia was significantly improved after treatment (P<0.001) with a relief rate of 79.8%, 80.7%, and 78.9%, respectively at 3months, 1year, and 2years after HIFU treatment.
With its ability to sustain long-term clinical improvements, HIFU is a safe and effective treatment for adenomyosis.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>26050604</pmid><doi>10.1016/j.ultsonch.2015.05.024</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1350-4177 |
| ispartof | Ultrasonics sonochemistry, 2015-11, Vol.27, p.677-681 |
| issn | 1350-4177 1873-2828 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1697220330 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Adenomyosis Adenomyosis - complications Adenomyosis - physiopathology Adenomyosis - surgery Adult Adverse effect Dysmenorrhea - complications Female Follow-Up Studies High-Intensity Focused Ultrasound Ablation - adverse effects Humans Long-term follow-up Menstruation Middle Aged Treatment Outcome Ultrasound-guided high-intensity focused ultrasound Young Adult |
| title | High-intensity focused ultrasound (HIFU) for adenomyosis: Two-year follow-up results |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T22%3A42%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High-intensity%20focused%20ultrasound%20(HIFU)%20for%20adenomyosis:%20Two-year%20follow-up%20results&rft.jtitle=Ultrasonics%20sonochemistry&rft.au=Shui,%20Lian&rft.date=2015-11-01&rft.volume=27&rft.spage=677&rft.epage=681&rft.pages=677-681&rft.issn=1350-4177&rft.eissn=1873-2828&rft_id=info:doi/10.1016/j.ultsonch.2015.05.024&rft_dat=%3Cproquest_cross%3E1697220330%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1697220330&rft_id=info:pmid/26050604&rft_els_id=S1350417715001534&rfr_iscdi=true |